Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis.

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37307297

about

Screening, diagnosis and treatment of osteoporosis: a brief review Bisphosphonates and risk of cardiovascular events: a meta-analysis.Therapy for patients with CKD and low bone mineral density.Management of osteoporosis of the oldest old.Long-term risks of bisphosphonate therapy.Fracture liaison services: promoting enhanced bone health care.The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate).Heart failure in patients treated with bisphosphonates.Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies.Observational studies--just telling us what we want to hear or telling us where we need to look?Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.

P2860

Q26996726-C5C6F339-AF9D-4A34-A790-16963BF60072 Q35462296-352B000C-EC11-4E15-8C1D-B95F78C8CD85 Q38150099-6AEA9A79-D420-44B0-B9A8-6D86F7B3AB48 Q38229503-0EE02533-DF3A-4082-B8CB-31FC35322652 Q38244171-D3BC1A52-F567-42F7-B61E-180633D0AB9C Q38252846-B0EAFE32-6689-4319-B220-EAAC877AE630 Q41689098-A48CD960-3187-48DD-B8AB-5FE8E399FD50 Q44389690-70F0B788-D13E-41A2-BD77-0786350030D3 Q44657342-3762030C-236D-4CF0-8799-ED4F19E713C9 Q46105591-C8190E42-5118-4E6E-B1C7-27F341DAF4CF Q51178470-825C6116-29E7-435A-A25C-38E6572588EC

P2860

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37307297

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@en

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@nl

type

label

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@en

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@nl

prefLabel

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@en

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@nl

P1433

Q37307297-9D105248-2392-406D-945D-5A00A0E8F509

P1476

Q37307297-46498D7C-9C12-4313-925E-D4BE27169B7C

P2093

Q37307297-14003B12-5C8F-4CFC-9CBD-1F23764B54B3

Q37307297-2278CB07-F707-4942-9F55-A32D968B0B73

Q37307297-83048E8C-881D-44D8-999E-4A43877CF432

Q37307297-BA12D8EE-5FC9-46F7-87CB-53A59B90BB5B

Q37307297-DC7D056B-A696-4D08-917A-9D439136D3B2

P2860

Q37307297-02213D19-7A34-4F88-94CD-EC642065F75B

Q37307297-095974A9-F9E7-465B-ADD6-D10CC81B2214

Q37307297-0FA75717-D312-4235-871E-51B2C3AB7A6B

Q37307297-1D8B10D1-809E-436D-B192-4A57035B4CE4

Q37307297-259E217B-04E9-49C7-A9E7-8950CA3BA9A1

Q37307297-32D27E76-CE74-4FCD-93D6-30D51EFA9835

Q37307297-3AEFBE5C-3F6C-41CC-8B2B-D50D15231590

Q37307297-44CC3311-7E10-454E-ADB4-8219295E045B

Q37307297-49116EF3-7FBE-445A-BCE8-22299480315A

Q37307297-4962DC49-7F2D-4098-8363-890018741236

P304

Q37307297-C0F9FEC8-316C-4E6E-BEF3-55A656A0FB01

P31

Q37307297-703C5D90-B3A5-4EF2-8F08-94150EB0B938

P356

Q37307297-CAA79CA0-444D-4DE1-BD11-45C5FEDFF807

P433

Q37307297-5468C743-FBA4-4D73-A91E-8D0421E3B582

P478

Q37307297-683CB813-8426-4617-95CF-0B45D193F5FD

P50

Q37307297-BC7F3FB4-2DBC-47E5-A38F-C95FCAA6228B

P577

Q37307297-25D44628-07AB-4A15-B4B9-FBB9D384CA71

P5875

Q37307297-9876D358-B489-420E-A2F1-1706E76037C4

P698

Q37307297-C9BB8F1F-537E-4D99-B740-85281ED2FF1D

P921

Q37307297-B0BB6F9D-4C43-4843-ADA0-25EEA8A3F3A7

P932

Q37307297-7ED82C63-3715-47E3-ABC2-DC3D9BE42364

P356

P1433

Journal of Bone and Mineral Research

P1476

Bisphosphonate use is associat ...... nts with rheumatoid arthritis.

@en

P2093

Cathleen S Colón-Emeric

http://www.w3.org/2001/XMLSchema#string

Christopher M O'Connor

http://www.w3.org/2001/XMLSchema#string

Kaleb Michaud

http://www.w3.org/2001/XMLSchema#string

Kenneth W Lyles

http://www.w3.org/2001/XMLSchema#string

Marcy B Bolster

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank.

Cardiovascular morbidity and mortality in rheumatoid arthritis.

Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events.

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis).

Meta-analysis: excess mortality after hip fracture among older women and men.

Recent advances in 99mTc radiopharmaceuticals.

P304

984-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.1792

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Frederick Wolfe

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232278463

http://www.w3.org/2001/XMLSchema#string

P698

23074131

http://www.w3.org/2001/XMLSchema#string

P921

P932

3827632

http://www.w3.org/2001/XMLSchema#string